JP3435181B2 - External preparation for melanin production suppression - Google Patents
External preparation for melanin production suppressionInfo
- Publication number
- JP3435181B2 JP3435181B2 JP00634393A JP634393A JP3435181B2 JP 3435181 B2 JP3435181 B2 JP 3435181B2 JP 00634393 A JP00634393 A JP 00634393A JP 634393 A JP634393 A JP 634393A JP 3435181 B2 JP3435181 B2 JP 3435181B2
- Authority
- JP
- Japan
- Prior art keywords
- yeast
- extract
- culture
- present
- melanin production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000008099 melanin synthesis Effects 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 14
- 230000001629 suppression Effects 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 40
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 39
- 239000000284 extract Substances 0.000 claims description 17
- 240000005979 Hordeum vulgare Species 0.000 claims description 9
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 9
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 6
- 102100022624 Glucoamylase Human genes 0.000 claims description 6
- 241000235070 Saccharomyces Species 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 5
- 241000894007 species Species 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 239000010457 zeolite Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 description 36
- 238000004519 manufacturing process Methods 0.000 description 24
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 230000003020 moisturizing effect Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000008213 purified water Substances 0.000 description 12
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 10
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- -1 cepharanthin Chemical compound 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 229940058015 1,3-butylene glycol Drugs 0.000 description 7
- 241000209140 Triticum Species 0.000 description 7
- 235000021307 Triticum Nutrition 0.000 description 7
- 235000019437 butane-1,3-diol Nutrition 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 229940024171 alpha-amylase Drugs 0.000 description 5
- 229960000735 docosanol Drugs 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- 210000005253 yeast cell Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 102000004139 alpha-Amylases Human genes 0.000 description 4
- 108090000637 alpha-Amylases Proteins 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 3
- 241001123227 Saccharomyces pastorianus Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 235000021302 avocado oil Nutrition 0.000 description 3
- 239000008163 avocado oil Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229920003002 synthetic resin Polymers 0.000 description 2
- 239000000057 synthetic resin Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SWFHGTMLYIBPPA-UHFFFAOYSA-N (4-methoxyphenyl)-phenylmethanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 SWFHGTMLYIBPPA-UHFFFAOYSA-N 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- NDNMXRYLRJEZAR-UHFFFAOYSA-N 2-[1-(4-methoxyphenyl)propylidene]octanoic acid Chemical compound CCCCCCC(C(O)=O)=C(CC)C1=CC=C(OC)C=C1 NDNMXRYLRJEZAR-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 244000050983 Luffa operculata Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940071120 dehydroacetate Drugs 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229940117383 elder extract Drugs 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 229940040511 liver extract Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
【発明の詳細な説明】
【0001】
【産業上の利用分野】本発明は、酵母培養液の外用剤へ
の応用に関するものであって、より詳しくは、特定の糖
化液に特定の菌種を接種した酵母培養液または培養エキ
スのメラニン生成抑制効果及び保湿効果を有効に利用し
たメラニン生成抑制外用剤に関する。
【0002】
【従来の技術】酵母の利用分野は広く、古くから酵母の
発酵生産物の利用が食品分野、医薬品分野でなされてい
る。特に酵母の菌体抽出エキスの利用が主流であり、酵
母の菌体抽出エキスの保湿効果ならびに皮膚美容効果を
利用し、化粧料等に配合することは公知である。例え
ば、酵母菌体そのものをパックに用いた特公昭39−4
899号公報、胎盤組成の酵素分解物と酵母エキスを混
合したメラニン生成抑制剤を開示する特公昭56−44
046号公報、RNAを50ないし5000PPM含有
する酵母抽出液を開示する特公昭61−260009号
公報、ならびにビール酵母菌体の有機溶媒抽出液を含有
する化粧料を開示する特公昭61−171405号公報
などが知られている。
【0003】酵母菌体抽出液の利用目的の多くのもの
は、その保湿性に注目したものであり、一部、他のもの
との相乗効果でメラニン生成を抑制することを目的とし
たものがある。従来の酵母の菌体から有用性物質を抽出
する方法では、菌体という少量しか得られないものを利
用しているため量産化が難しかった。一方、酵母の培養
液を利用した例としては、酵母培養液ないしは酵母エキ
スを有効成分とする貧血改善組成物を開示する特公昭6
1−118322号公報、コールドウェーブ用糖発酵液
を開示する特公昭64−11612号公報が見られるだ
けで、皮膚外用剤としての利用は知られていない。
【0004】
【本発明が解決しようとする課題】そこで本発明の目的
は、保湿性を高める物質ばかりでなく、化粧品類に求め
られるメラニン生成抑制効果を示す物質にも注目し、培
養液中に両者を生産させ、また、その濃度を高めること
により、メラニン生成抑制効果及び保湿効果を有した外
用剤を提供することにある。
【0005】
【課題を解決するための手段】本発明は、前記目的を達
成するために提案されたものであり、特定の糖化液に特
定の菌種を接種した酵母培養液または培養エキスにメラ
ニン生成抑制効果および保湿効果があるという本発明者
によって得られた知見に基づいて完成されたものであ
る。すなわち、本発明によれば、麦類に、糖化酵素とし
て、α−アミラーゼとグルコアミラーゼを同時添加して
得られた糖化液に、菌種としてサッカロミセスセレビシ
エまたはサッカロミセスカールスベルゲンシスを接種し
た酵母培養液または培養エキスを含有することを特徴と
するメラニン生成抑制外用剤が提供される。
【0006】
【発明の具体的説明】本発明者は、サッカロミセス属の
酵母を用い、培養液中にメラニン生成抑制物質および保
湿性成分を生産すべく鋭意研究を行い、培養細胞(B1
6細胞)を使った実験において、糖液、特に麦類を用い
た培地でサッカロミセス属の酵母を培養した液が色素細
胞のメラニン生成を強く抑えることを見出し、同時に強
い保湿性を有することを確認して本発明を完成した。
【0007】本発明における酵母培養液とは、培養液自
体または培養液をメンブランフィルター等でろ過または
遠心分離機等で除菌したもの、ないしはメラニン生成抑
制物質濃度を高める処理をした溶液を言い、培養エキス
とはこの培養液を減圧濃縮機等で濃縮したものを言う。
本発明におけるサッカロミセス属の酵母としては、サッ
カロミセスセレビシエ(Saccharomyces cerevisiae)ま
たはサッカロミセスカールスベルゲンシス(Saccharomy
ces carlsbergensis)が用いられ、中でもサッカロミセ
スセレビシエがより有効である。
【0008】本発明における糖液すなわち炭素源として
は、麦類(例えば、大麦、小麦、ライ麦、エン麦等)ま
たは麦類に水を加え加熱膨潤後、糖化酵素として、αー
アミラーゼとグルコアミラーゼとを同時に添加したもの
を培地に使用するものであり、これによって酵母による
メラニン生成抑制物質の生産が高くなる。
【0009】また、糖液中に窒素源が充分に含まれない
場合には、ペプトン、大豆蛋白加水分解物、アンモニウ
ム塩、アミノ酸等を適量添加するのが好ましい。本発明
における酵母培養液のメラニン生成抑制効果は、培養液
またはその濃縮液でも充分であるが、さらにアルコール
類などの、有機溶媒添加、塩析、吸着剤、カラムクロマ
トによる分画によって効果を高めることも可能である。
以上の様にして得られた本発明の酵母培養液ないしは培
養エキスは、メラニン生成抑制効果および保湿効果に優
れており、皮膚に対し何ら傷害などのトラブルを与える
ものでなく安全性にも優れている。
【0010】本発明のメラニン生成抑制外用剤は、前述
の有効成分を皮膚施用上許容し得る公知の剤型に配合し
て製造するものであり、その配合量は培養方法や配合す
る製剤の形態によって異なるが、通常、培養液または培
養エキスを製剤中に0.05ないし50重量%、好まし
くは0.1ないし10重量%程度配合すると良い。
【0011】さらに、本発明の有効成分の他に通常に用
いられる種々の公知の有効成分、例えば、ビタミンE、
ビタミンEニコチネート、ニコチン酸、ニコチン酸アミ
ド、ニコチン酸ベンジル等のビタミン剤、セファランチ
ン、ショウキョウチンキ、トウガラシチンキなどの末梢
血管拡張剤、カンフル、メントールなどの清涼剤、ヒノ
キチオール、塩化ベンザルコニウム、ウンデシレン酸な
どの抗菌剤、塩化リゾチーム、グリチルリチン、アラン
トインなどの消炎剤、コウジ酸及びその誘導体、アスコ
ルビン酸及びその誘導体、アルブチン リキリチン及び
その誘導体等の色白剤、センブリエキス、ニンニクエキ
ス、ニンジンエキス、オウゴンエキス、ローズマリーエ
キス、アロエエキス、ヘチマ抽出物、イチョウ抽出物、
ニワトコ抽出物、胎盤抽出液、肝臓抽出物、乳酸菌培養
抽出物などの動物、植物、微生物由来の各種抽出物など
を自由に添加して使用することができる。
【0012】本発明の外用剤の公知の剤型とは、外用可
能なあらゆる剤型を意味し、例えばパップ剤、プラスタ
ー剤、ペースト剤、クリーム、軟膏、エアゾール剤、乳
剤、ローション、乳液、エッセンス、パック、ゲル剤、
パウダー、ファンデーション、サンケア、バスソルト、
石鹸類などの皮膚適用剤が例示できる。また、前述の外
用剤には、メラニン生成抑制外用剤としての効果を損な
わない限り、公知の有効成分の他に、界面活性剤、油脂
類などの基剤成分や、必要に応じて公知の保湿剤、増粘
剤、防腐剤、酸化防止剤、紫外線吸収剤、散乱剤、キレ
ート剤、pH調整剤、香料、着色剤など種々の添加剤を
併用できる。
【0013】保湿剤としては、例えば、グリセリン、プ
ロピレングリコール、1,3−ブチレングリコール、ソ
ルビトール、マンニトール、ポリエチレングリコール、
ジプロピレングリコール等の多価アルコール類、アミノ
酸、乳酸ナトリウム、ピロリドンカルボン酸ナトリウム
等のNMF成分、ヒアルロン酸、コラーゲン、エラスチ
ン、コンドロイチン硫酸、デルマタン硫酸、フィブロネ
クチン、セラミド類、ヘパリン類似様物質、キトサン等
の水溶性高分子物質などを例示することができる。
【0014】増粘剤としては、例えば、アルギン酸ナト
リウム、キサンタンガム、ケイ酸アルミニウム、マルメ
ロ種子抽出物、トラガントゴム、デンプン等の天然高分
子物質、メチルセルロース、ヒドロキシエチルセルロー
ス、カルボキシメチルセルロース、可溶性デンプン、カ
チオン化セルロース等の半合成高分子物質、カルボキシ
ビニルポリマー、ポリビニルアルコール等の合成高分子
物質等を例示することができる。
【0015】防腐剤としては、例えば安息香酸塩、サリ
チル酸塩、ソルビン酸塩、デヒドロ酢酸塩、パラオキシ
安息香酸エステル、2,4,4’ートリクロロー2’ー
ヒドロキシジフェニルエーテル、3,4,4’ートリク
ロロカルバニリド、塩化ベンザルコニウム、ヒノキチオ
ール、レゾルシン、エタノール等を例示することができ
る。
【0016】酸化防止剤としては、例えば、ジブチルヒ
ドロキシトルエン、ブチルヒドロキシアニソール、没食
子酸プロピル、アスコルビン酸等を例示することができ
る。
【0017】紫外線吸収剤としては、例えば、4−メト
キシベンゾフェノン、オクチルジメチルパラアミノベン
ゾエート、エチルヘキシルパラメトキシサイナメート、
酸化チタン、カオリン、タルク等を例示することができ
る。
【0018】さらに、キレート剤としては、例えば、エ
チレンジアミン四酢酸塩、ピロリン酸塩、ヘキサメタリ
ン酸塩、クエン酸塩、酒石酸、グルコン酸等を例示する
ことができ、pH調整剤としては、水酸化ナトリウム、
リン酸水素カリウム等をそれぞれ例示することができ
る。
【0019】
【実施例】以下に、本発明の製造例、その効果を説明す
るための試験例ならびに処方例を挙げるが、これらは本
発明を何ら限定するものではない。
【0020】<製造例1>押し麦(大麦)1kg、グル
コース400g、大豆蛋白加水分解物80gに精製水1
8.52リットルを加え、pHを5に調整後、120℃
で15分間加熱殺菌し30℃に冷却後、α−アミラーゼ
及びグルコアミラーゼを等量ずつ少量無菌的に加え、酵
母(Saccharomyces cerevisiae)の種菌をこれに接種
し、30℃で培養液中のグルコース残量が0.1ないし
0.5%になるまで約6日間培養した。培養液をメンブ
ランフィルター(0.25μ)で除菌後、5倍濃縮して
本発明品約4kgを得た。
【0021】<製造例2>小麦1.4kgに精製水12
リットルを加え、煮沸膨潤後40℃まで冷却しα−アミ
ラーゼ及びグルコアミラーゼを等量ずつ少量加え約2時
間糖化する。この糖化液にペプトン100g、精製水
6.5リットルを加え、pHを5に調整後、120℃で
15分間加熱殺菌し冷却後、酵母(Saccharomyces cere
visiae)の種菌をこれに接種し、30℃で培養液中のグ
ルコース残量が0.1ないし0.5%になるまで約6日
間培養した。培養液を遠心分離により除菌後、10倍濃
縮して本発明品約2kgを得た。
【0022】<製造例3>蒸した大麦1kg、ペプトン
40gに精製水18.96リットルを加え、120℃で
15分間加熱殺菌し冷却後、酵母(Saccharomyces cere
visiae)の種菌をこれに接種し、30℃で7日間培養し
た。培養液を遠心分離して除菌後、5倍濃縮し本発明品
約4kgを得た。
【0023】<製造例4>大麦1kg、グルコース40
0g、ペプトン200gに0.1Mのリン酸緩衝液(p
H5)18.6kgを加え、120℃で15分間加熱殺
菌し冷却後、酵母(Saccharomyces carlsbergensis)の
種菌をこれに接種し、32℃で約8日間培養した。培養
液を遠心分離して除菌後、減圧濃縮機にて10倍濃縮
し、本発明品約2kgを得た。
【0024】<製造例5>蒸した大麦1.2kg、肉汁
200gに精製水18.6リットルを加え、pHを5に
調整後、120℃で10分間加熱殺菌し冷却後、マルタ
ーゼを少量無菌的に加え糖化する。これに酵母(Saccha
romyces cerevisiae)の種菌を接種し、30℃で8日間
培養した。培養液をメンブランフィルターで除菌後、減
圧濃縮機で10倍濃縮し本発明品約2kgを得た。
【0025】<製造例6>小麦800g、トウモロコシ
澱粉400g、水18.8リットルを煮沸膨潤後、40
℃に保持しながらα−アミラーゼ及びグルコアミラーゼ
を等量ずつ少量加え、約2時間糖化した。この糖化液を
pH5に調整後、120℃で15分間加熱殺菌し冷却
後、酵母(Saccharomyces cerevisiae)の種菌を接種
し、30℃で培養液中のグルコース量が0.5%以下に
なるまで約8日間培養した。培養液を遠心分離により除
菌後、合成樹脂セパビーズSP−205(三菱化成工業
株式会社製)を6%添加後1時間撹拌し、合成樹脂をろ
別した。ろ液を減圧濃縮器で10分の1量まで濃縮し本
発明品約2kgを得た。
【0026】<実験例1> マウスメラノーマB16細
胞による白色化試験方法
試料をMEM(Eagle's Minimum Essential Medium)に
最終濃度が表1に示す濃度になるように調製、溶解し、
孔径0.45μmの除菌フィルターでろ過した。MEM
に不溶性の試料は、100μlのエタノールに溶解後、
MEMに添加した。2枚のプラスチックシャーレ(Falc
on製、内径9cm)にそれぞれ、試料を溶解、ろ過除菌
したMEMを8ml、FBS(ウシ胎児血清)1mlお
よびMEM1mlに懸濁した1×105 /mlのB16
細胞を添加し、培養開始3日後に培地交換を行い、計5
日間、5%CO2 、95%空気条件下、37℃で培養し
た。培養終了後、シャーレの底に増殖した細胞を集め、
Phosphate buffered saline(PBS)に懸濁させ、2
000rpmで3分間遠心分離を行い、得られた細胞ペ
レットの黒化度を肉眼的に評価した。
【0027】表1において、肉眼的色調における+−
は、下記の評価を示す。
±:無添加区と同程度の黒化度を示す。
+:無添加区よりやや少ない黒化度を示す。
++:無添加区より明らかに少ない黒化度を示す。
+++:僅かに認められる黒化度を示す。
++++:白色ないし灰色で黒色と認められない。
+++++:白色
【0028】
【0029】<実験例2> モルモット紫外線色素沈着
抑制効果
黄褐色モルモットを用い、色素沈着の改善効果を調べ
た。この結果を表2に示す。
[試験方法]黄褐色モルモット10匹の背部皮膚を用
い、該モルモットの背部毛をバリカンにて刈毛し、更に
電気カミソリにて剃毛した。このモルモットの背部を、
4ヶ所9正方形(2.0×2.0cm)の穴の開いたア
ルミ箔で覆い、UV−B(SEランプ3本、140mJ
/cm2 )で1日1回90秒、3日毎に4回照射した。
照射開始日から、「麦発酵液」(製造例1ないし3)
を、1日3回20日間連続して塗布した。塗布開始後1
3日目から20日目の間に判定を行った。皮膚色の黒化
度は以下に示した判定基準にて肉眼判定した。
【0030】判定基準
著効:色素沈着を全く認めない。
有効:わずかな色素沈着を認める。
やや有効:中程度の色素沈着を認める。
無効:コントロール部位と変わらない。
逆転:コントロールよりも強い色素沈着を認める。
【0031】【0032】<実験例3> インピーダンスメーターに
よる保湿性試験
[試験方法]高周波インピーダンスメーター(IBS社
製:MODEL IB-335)を用い、精製水をコントロールとし
て5%の酵母培養液(製造例1)の保湿性を調べた。他
の保湿剤と比較するために、保湿性が高いヒアルロン酸
ナトリウムの0.5%溶液を対照として同様に調べた。
[測定方法]ヒト前腕屈側部に試料を塗布(2cm×2
cm)し、30秒後すばやくガーゼで軽くふき取り、3
0秒毎に皮膚の電導度(コンダクタンス)を経時的に1
0分まで測定した(測定条件:測定室内温度20℃、湿
度60%、測定回数n=10)。
[試験結果]結果を図1に示した。図1の結果は、電導
度が高いほど保湿性が高いことを示しており、本発明の
酵母培養液は、保湿剤として優れていることが確認され
た。
【0033】以下に処方例を示す。なお、処方例中、
「適量」とは、処方全量が100重量%になる量を意味
する。
【0034】
<処方例1> クリーム
(重量%)
1.モノステアリン酸ポリエチレングリコール(40E.0.) 2.00
2.自己乳化型モノステアリン酸グリセリン 5.00
3.ステアリン酸 5.00
4.ベヘニルアルコール 1.00
5.流動パラフィン 10.00
6.トリオクタン酸グリセリル 10.00
7.酵母発酵液(製造例1で得られたもの) 4.00
8.パラオキシ安息香酸エステル 0.20
9.1,3ーブチレングリコール 5.00
10.エデト酸二ナトリウム 0.01
11.精製水 適量
製造方法
A.1ないし7を加温、溶解する。
B.8ないし12を加温、溶解する。
C.AにBを加え乳化、撹拌し、冷却する
D.Cを冷却後、容器に充填し、検査後製品とする。
用法及び用量
適量を顔面に塗擦する。
【0035】
<処方例2> 乳液 (重量%)
1.モノステアリン酸ポリオキシエチレンソルビタン(20E.0.) 2.00
2.テトラオレイン酸ポリオキシエチレンソルビット(60E.0.) 0.50
3.親油型モノステアリン型グリセリン 1.00
4.ステアリン酸 0.50
5.ベヘニルアルコール 0.50
6.アボガド油 4.00
7.トリオキタン酸グリセリル 4.00
8.酵母発酵液(製造例3で得られたもの) 3.00
9.パラオキシ安息香酸エステル 0.20
10.1,3ーブチレングリコール 5.00
11.キサンタンガム 0.14
12.エデト酸二ナトリウム 0.01
13.精製水 適量
製造方法
A.1ないし8を加温、溶解する。
B.9ないし14を加温、溶解する。
C.AにBを加え乳化、撹拌し、冷却する
D.Cを冷却後、容器に充填し、検査後製品とする。
用法及び用量
適量を顔面に塗擦する。
【0036】
<処方例3> ローション剤
(重量%)
1.ポリオキシエチレン硬化ヒマシ油(60E.0.) 8.00
2.エタノール 15.00
3.酵母発酵液(製造例6で得られたもの) 5.00
4.パラオキシ安息香酸エステル 0.10
5.クエン酸 0.10
6.クエン酸ナトリウム 0.30
7.1,3ーブチレングリコール 4.00
8.エデト酸二ナトリウム 0.01
9.精製水 適量
製造方法
A.1ないし10を均一に撹拌、溶解する。
B.Aを容器に充填し、検査後製品とする。
用法及び用量
適量を顔面に塗擦する。
【0037】
<処方例4> クリームパック
(重量%)
1.モノステアリン酸ポリエチレングリコール(40 E.0. ) 2.00
2.自己乳化型モノステアリン酸グリセリン 5.00
3.ステアリン酸 5.00
4.ベヘニルアルコール 0.50
5.スクワラン 15.00
6.オクタン酸セチル 5.00
7.酵母発酵液(製造例2で得られたもの) 5.00
8.パラオキシ安息香酸エステル 0.20
9.1,3−ブチレングリコール 5.00
10.エデト酸二ナトリウム 0.01
11.精製水 適量
製造方法
A.1ないし7を加温、溶解する。
B.8ないし12を加温、溶解する。
C.AにBを加え乳化、撹拌し、冷却する
D.Cを冷却後、容器に充填し、検査後製品とする。
用法及び用量
適量を顔面に塗擦する。
【0038】
<処方例5> 軟膏剤
(重量%)
1.モノステアリン酸ポリオキシエチレンソルビタン(20E.0.) 1.00
2.テトラオレイン酸ポリオキシエチレンソルビット(60E.0.) 1.50
3.自己乳化型モノステアリン酸グリセリン 1.50
4.サラシミツロウ 2.00
5.パラフィン 2.00
6.ステアリン酸 3.00
7.ベヘニルアルコール 3.00
8.流動パラフィン 5.00
9.アボガド油 12.00
10.ビタミンE 12.00
11.酵母発酵液(製造例4で得られたもの) 10.00
12.パラオキシ安息香酸エステル 0.20
13.1,3ーブチレングリコール 5.00
14.精製水 適量
製造方法
A.1ないし11を加温、溶解する。
B.12ないし15を加温、溶解する。
C.AにBを加え乳化、撹拌し、冷却する
D.Cを冷却後、容器に充填し、検査後製品とする。
用法及び用量
適量を顔面に塗擦する。
【0039】
<処方例6> 乳剤
(重量%)
1.モノステアリン酸ポリオキシエチレンソルビタン(20E.0.) 1.00
2.テトラオレイン酸ポリオキシエチレンソルビット(60E.0.) 0.50
3.親油型モノステアリン酸グリセリン 1.00
4.ステアリン酸 0.50
5.ベヘニルアルコール 0.50
6.アボガド油 4.00
7.トリオクタン酸グリセリル 4.00
8.酵母発酵液(製造例5で得られたもの) 3.00
9.パラオキシ安息香酸エステル 0.20
10.1,3ーブチレングリコール 5.00
11.キサンタンガム 0.14
12.エデト酸二ナトリウム 0.01
13.精製水 適量
製造方法
A.1ないし8を加温、溶解する。
B.9ないし14を加温、溶解する。
C.AにBを加え乳化、撹拌、冷却する
D.Cを冷却後、容器に充填し、検査後製品とする。
用法及び用量
適量を顔面に塗擦する。
【0040】
【発明の効果】本発明によれば、麦類に特定の糖化酵素
を同時に添加して得られた糖化液に、特定の菌種を接種
した酵母培養液または酵母エキスからなるメラニン生成
抑制効果に著しく優れた外用剤が提供され、この外用剤
は、保湿効果にも優れているために、しっとり感が求め
られる色白化粧料の有効成分として好適に使用される。Description: BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the application of a yeast culture to an external preparation, and more particularly, to a specific sugar.
The present invention relates to an external preparation for inhibiting melanin production, which effectively utilizes a melanin production inhibitory effect and a moisturizing effect of a yeast culture solution or a culture extract inoculated with a specific bacterial species in a chemical solution . [0002] The field of utilization of yeast is wide, and fermentation products of yeast have been used in the food and pharmaceutical fields for a long time. In particular, the use of yeast cell extract is the mainstream, and it is known that yeast extract is used in cosmetics and the like utilizing the moisturizing effect and skin cosmetic effect of yeast extract. For example, Japanese Patent Publication No. 39-4 using a yeast cell itself as a pack
No. 899, JP-B-56-44 discloses a melanin production inhibitor comprising a mixture of an enzyme hydrolyzate having a placental composition and a yeast extract.
No. 046, Japanese Patent Publication No. 61-260009, which discloses a yeast extract containing 50 to 5000 PPM of RNA, and Japanese Patent Publication No. 61-171405, which discloses a cosmetic containing an organic solvent extract of brewer's yeast cells. Etc. are known. [0003] Many uses of yeast cell extracts are focused on their moisturizing properties, and some of them are intended to suppress the production of melanin by a synergistic effect with others. is there. Conventional methods for extracting useful substances from yeast cells have been difficult to mass-produce because cells that can be obtained only in small amounts are used. On the other hand, as an example using a yeast culture solution, Japanese Patent Publication No. Sho 6 (1995) discloses an anemia ameliorating composition containing a yeast culture solution or a yeast extract as an active ingredient.
No. 1-118322 and Japanese Patent Publication No. 64-11612, which disclose a sugar fermentation solution for cold waves, are only found, but their use as skin external preparations is not known. Accordingly, an object of the present invention is to focus not only on substances that enhance moisturizing properties but also on substances that exhibit the melanin production inhibitory effect required for cosmetics, An object of the present invention is to provide an external preparation having a melanin production inhibitory effect and a moisturizing effect by producing both of them and increasing their concentrations. SUMMARY OF THE INVENTION The present invention has been proposed to achieve the above-mentioned object, and a melanin is added to a yeast culture or a culture extract obtained by inoculating a specific saccharified solution with a specific bacterial species. The present invention has been completed based on the knowledge obtained by the present inventor that it has a production suppressing effect and a moisturizing effect. That is, according to the present invention, wheat is converted into a saccharifying enzyme.
And simultaneously adding α-amylase and glucoamylase
An external preparation for suppressing melanin production, characterized in that the obtained saccharified solution contains a yeast culture solution or a culture extract inoculated with Saccharomyces cerevisiae or Saccharomyces curlsbergensis as a bacterial species. DETAILED DESCRIPTION OF THE INVENTION The present inventors have conducted intensive studies using yeast of the genus Saccharomyces to produce a melanogenesis inhibitor and a moisturizing component in a culture solution.
6 cells), it was found that a culture solution of yeast of the genus Saccharomyces in a sugar solution, particularly a medium using wheat, strongly suppresses the production of melanin by pigment cells, and at the same time, has a strong moisturizing property. Thus, the present invention has been completed. In the present invention, the term "yeast culture solution" refers to a culture solution itself or a culture solution obtained by filtering the culture solution with a membrane filter or the like and removing the bacteria with a centrifugal separator or the like, or a solution that has been treated to increase the concentration of a melanin production inhibitor. The culture extract is obtained by concentrating this culture solution with a vacuum concentrator or the like.
The yeast Saccharomyces according to the present invention, whip
Saccharomyces cerevisiae
Or Saccharomyces Carlsbergensis (Saccharomy
ces carlsbergensis), among which Saccharomyces cerevisiae is more effective. In the present invention, the sugar solution, that is, the carbon source, is barley (eg, barley, wheat, rye, oat, etc.) or barley, which is heated and swelled , and then α-α
Amylase and glucoamylase added simultaneously
The is intended to be used in the medium, thereby increases the production of melanin production inhibitors by yeast. When the sugar solution does not sufficiently contain a nitrogen source, it is preferable to add peptone, a soybean protein hydrolyzate, an ammonium salt, an amino acid and the like in an appropriate amount. The melanin production inhibitory effect of the yeast culture solution in the present invention is sufficient even with a culture solution or a concentrated solution thereof, but the effect is further enhanced by addition of an organic solvent such as alcohols, salting out, an adsorbent, and fractionation by column chromatography. It is also possible.
The yeast culture solution or culture extract of the present invention obtained as described above has an excellent melanin production inhibitory effect and a moisturizing effect, and does not cause any trouble such as damage to the skin and is also excellent in safety. I have. The external preparation for inhibiting melanin production of the present invention is prepared by blending the above-mentioned active ingredient in a known dosage form which is acceptable for skin application. Usually, it is advisable to mix the culture solution or culture extract in the preparation at about 0.05 to 50% by weight, preferably about 0.1 to 10% by weight. Further, in addition to the active ingredient of the present invention, various known active ingredients usually used, for example, vitamin E,
Vitamin E such as vitamin E nicotinate, nicotinic acid, nicotinamide, and benzyl nicotinate; peripheral vasodilators such as cepharanthin, ginger tincture, and capsicum tincture; refreshing agents such as camphor and menthol; hinokitiol; benzalkonium chloride; undecylene Antibacterial agents such as acid, anti-inflammatory agents such as lysozyme chloride, glycyrrhizin, allantoin, whitening agents such as kojic acid and its derivatives, ascorbic acid and its derivatives, arbutin liquiritin and its derivatives, assembly extracts, garlic extract, carrot extract, and gongon extract , Rosemary extract, aloe extract, luffa extract, ginkgo extract,
Various extracts derived from animals, plants, and microorganisms, such as elder extract, placenta extract, liver extract, and lactic acid bacteria culture extract, can be freely added and used. The known dosage form of the external preparation of the present invention means any dosage form that can be used externally, such as cataplasms, plasters, pastes, creams, ointments, aerosols, emulsions, lotions, emulsions, and essences. , Packs, gels,
Powder, foundation, sun care, bath salt,
Skin application agents such as soaps can be exemplified. In addition, the above-mentioned external preparations include, in addition to known active ingredients, surfactants, base components such as oils and fats, and a known moisturizing agent, if necessary, as long as the effect as the external preparation for suppressing melanin production is not impaired. Various additives such as agents, thickeners, preservatives, antioxidants, ultraviolet absorbers, scattering agents, chelating agents, pH adjusters, fragrances and coloring agents can be used in combination. Examples of humectants include glycerin, propylene glycol, 1,3-butylene glycol, sorbitol, mannitol, polyethylene glycol,
Polyhydric alcohols such as dipropylene glycol, amino acids, NMF components such as sodium lactate and sodium pyrrolidone carboxylate, hyaluronic acid, collagen, elastin, chondroitin sulfate, dermatan sulfate, fibronectin, ceramides, heparin-like substances, chitosan, etc. Examples include water-soluble polymer substances. Examples of the thickener include sodium alginate, xanthan gum, aluminum silicate, quince seed extract, tragacanth gum, natural polymer substances such as starch, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, soluble starch, cationized cellulose and the like. And a synthetic polymer such as carboxyvinyl polymer and polyvinyl alcohol. Examples of preservatives include benzoate, salicylate, sorbate, dehydroacetate, paraoxybenzoate, 2,4,4'-trichloro-2'-hydroxydiphenyl ether, 3,4,4'-trichloroform. Examples include carbanilide, benzalkonium chloride, hinokitiol, resorcinol, ethanol and the like. Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, propyl gallate, ascorbic acid and the like. Examples of the ultraviolet absorber include 4-methoxybenzophenone, octyldimethylparaaminobenzoate, ethylhexylparamethoxycinnamate,
Examples include titanium oxide, kaolin, and talc. Further, examples of the chelating agent include ethylenediaminetetraacetate, pyrophosphate, hexametaphosphate, citrate, tartaric acid, gluconic acid, and the like. ,
Examples thereof include potassium hydrogen phosphate. EXAMPLES The following are production examples of the present invention, test examples and prescription examples for explaining the effects thereof, but they do not limit the present invention in any way. <Production Example 1> 1 kg of barley (barley), 400 g of glucose, 80 g of hydrolyzate of soybean protein and 1 g of purified water
After adding 8.52 liters and adjusting the pH to 5, the temperature was adjusted to 120 ° C.
After heating for 15 minutes and cooling to 30 ° C, equal amounts of α-amylase and glucoamylase are aseptically added in small amounts, and inoculum of yeast (Saccharomyces cerevisiae) was inoculated thereto. The cells were cultured for about 6 days until the amount became 0.1 to 0.5%. The culture was sterilized with a membrane filter (0.25 µ) and then concentrated 5 times to obtain about 4 kg of the product of the present invention. <Production Example 2> Purified water was added to 1.4 kg of wheat.
Then, the mixture is boiled and swollen, cooled to 40 ° C., and α-amylase and glucoamylase are added in small amounts in equal amounts to saccharify for about 2 hours. 100 g of peptone and 6.5 liters of purified water were added to the saccharified solution, the pH was adjusted to 5, and the mixture was sterilized by heating at 120 ° C. for 15 minutes, cooled, and then subjected to yeast (Saccharomyces cerevisiae).
visiae), and cultured at 30 ° C. for about 6 days until the residual amount of glucose in the culture solution became 0.1 to 0.5%. The culture was sterilized by centrifugation and then concentrated 10 times to obtain about 2 kg of the product of the present invention. <Production Example 3> To 1 kg of steamed barley and 40 g of peptone, 18.96 liters of purified water was added, sterilized by heating at 120 ° C. for 15 minutes, and cooled, followed by yeast (Saccharomyces cereal).
visiae) was inoculated thereto and cultured at 30 ° C. for 7 days. The culture was centrifuged to remove bacteria, and then concentrated 5 times to obtain about 4 kg of the product of the present invention. <Production Example 4> 1 kg of barley, 40 glucose
0 g and 200 g of peptone in 0.1 M phosphate buffer (p
H5) 18.6 kg was added, the mixture was sterilized by heating at 120 ° C. for 15 minutes, cooled, and then inoculated with yeast (Saccharomyces carlsbergensis), and cultured at 32 ° C. for about 8 days. The culture was centrifuged to remove bacteria, and then concentrated 10-fold with a vacuum concentrator to obtain about 2 kg of the product of the present invention. <Production Example 5> 18.6 liters of purified water was added to 1.2 kg of steamed barley and 200 g of broth, the pH was adjusted to 5, and the mixture was sterilized by heating at 120 ° C for 10 minutes. And saccharified. Yeast (Saccha)
romyces cerevisiae) and inoculated at 30 ° C. for 8 days. The culture was sterilized with a membrane filter and then concentrated 10-fold with a vacuum concentrator to obtain about 2 kg of the product of the present invention. <Production Example 6> 800 g of wheat, 400 g of corn starch, and 18.8 liters of water were boiled and swollen, and then heated to 40 g.
While maintaining at ℃, α-amylase and glucoamylase were added in small amounts in equal amounts, and saccharified for about 2 hours. This saccharified solution was adjusted to pH 5, sterilized by heating at 120 ° C. for 15 minutes, cooled, and inoculated with a yeast (Saccharomyces cerevisiae) inoculum. At 30 ° C., the amount of glucose in the culture solution was reduced to 0.5% or less. Cultured for 8 days. After removing the bacteria by centrifugation of the culture solution, 6% of synthetic resin Sepabeads SP-205 (manufactured by Mitsubishi Kasei Kogyo Co., Ltd.) was added, followed by stirring for 1 hour, and the synthetic resin was filtered off. The filtrate was concentrated to one-tenth volume with a vacuum concentrator to obtain about 2 kg of the product of the present invention. <Experimental example 1> Mouse melanoma B16 fine
Test method for whitening using cells Prepare and dissolve the sample in MEM (Eagle's Minimum Essential Medium) so that the final concentration is as shown in Table 1.
The solution was filtered through a sterilizing filter having a pore size of 0.45 μm. MEM
The insoluble sample was dissolved in 100 μl of ethanol,
Added to MEM. Two plastic Petri dishes (Falc
1 × 10 5 / ml B16 suspended in 8 ml of MEM, 1 ml of FBS (fetal bovine serum) and 1 ml of MEM, each of which was dissolved and filtered and sterilized.
The cells were added, and the medium was replaced three days after the start of the culture.
The cells were cultured at 37 ° C. for 5 days under the conditions of 5% CO 2 and 95% air. After culturing, collect the cells grown on the bottom of the Petri dish,
Suspend in Phosphate buffered saline (PBS) and add 2
Centrifugation was performed at 000 rpm for 3 minutes, and the degree of blackening of the obtained cell pellet was visually evaluated. In Table 1, +-
Indicates the following evaluation. ±: shows the same degree of blackening as the non-added group. +: Shows a slightly lower degree of blackening than the non-added group. ++: The degree of blackening is clearly lower than that of the non-added group. +++: Degree of blackening slightly observed. ++++: White to gray, not recognized as black. ++++++: white color <Experimental example 2> Guinea pig ultraviolet pigmentation
Inhibitory effect The effect of improving pigmentation was examined using tan guinea pigs. Table 2 shows the results. [Test Method] Using the skin of the back of ten tan guinea pigs, the back hair of the guinea pig was shaved with a clipper and further shaved with an electric razor. The back of this guinea pig,
UV-B (three SE lamps, 140 mJ) covered with aluminum foil with holes of 9 squares (2.0 x 2.0 cm) at four places
/ Cm 2 ) once a day for 90 seconds, three times every three days.
"Wheat fermented liquor" from the start of irradiation (Production Examples 1 to 3 )
Was applied three times a day for 20 consecutive days. 1 after start of application
The judgment was made between the 3rd and 20th days. The degree of blackening of the skin color was visually determined according to the following criteria. Evaluation criteria Excellent: no pigmentation was observed. Effective: slight pigmentation is observed. Moderately effective: moderate pigmentation is observed. Invalid: No difference from control site. Reversal: stronger pigmentation than control is observed. [0031] <Experimental example 3> Impedance meter
According moisture Test [Test method] frequency impedance meter (IBS Co.: MODEL IB-335) used to examine the moisture of 5% yeast culture of purified water as a control (preparation 1). For comparison with other humectants, a 0.5% solution of sodium hyaluronate having high moisturizing properties was similarly examined as a control. [Measurement method] Apply sample to human forearm flexion side (2 cm × 2
cm), and after 30 seconds, quickly and gently wipe with gauze.
Every 0 seconds, the skin conductance (conductance) is increased by 1 over time.
Measurement was performed up to 0 minutes (measurement conditions: measurement room temperature 20 ° C., humidity 60%, number of measurements n = 10). [Test Results] The results are shown in FIG. The results in FIG. 1 show that the higher the conductivity, the higher the moisturizing property, and it was confirmed that the yeast culture solution of the present invention was excellent as a moisturizing agent. The following are formula examples. In the prescription examples,
“Appropriate amount” means an amount that makes the total amount of the formulation 100% by weight. <Prescription Example 1> Cream (% by weight) Polyethylene glycol monostearate (40E.0.) 2.00 2. 2. Self-emulsifying glyceryl monostearate 5.00 Stearic acid 5.00 4. Behenyl alcohol 1.005. Liquid paraffin 10.00 6. Glyceryl trioctanoate 10.00 7. 7. Fermented yeast liquor (obtained in Production Example 1) 4.00 Paraoxybenzoate 0.20 9.1 1,3-butylene glycol 5.00 10. Disodium edetate 0.01 11. Purified water Proper quantity production method A. Heat and dissolve 1 to 7. B. Heat and dissolve 8-12. C. A. Add B to A, emulsify, stir and cool. After cooling, C is filled into a container, and is used as a product after inspection. Rub face and appropriate dosage and dosage. <Formulation Example 2> Emulsion (% by weight) Polyoxyethylene sorbitan monostearate (20E.0.) 2.00 2. 2. Polyoxyethylene sorbite tetraoleate (60E.0.) 0.50 3. Lipophilic monostearin type glycerin 1.00 Stearic acid 0.50 5. Behenyl alcohol 0.50 6. Avocado oil 4.00 7. Glyceryl trioxitanate 4.00 8. 8. Yeast fermentation liquor (obtained in Production Example 3) 3.00 Paraoxybenzoate 0.20 10.1,3 Butylene glycol 5.00 11. Xanthan gum 0.14 12. Disodium edetate 0.01 13. Purified water Proper quantity production method A. Heat and dissolve 1-8. B. Heat and dissolve 9-14. C. A. Add B to A, emulsify, stir and cool. After cooling, C is filled into a container, and is used as a product after inspection. Rub face and appropriate dosage and dosage. <Formulation Example 3> Lotion agent (% by weight) Polyoxyethylene hydrogenated castor oil (60E.0.) 8.00 2. Ethanol 15.00 3. 3. Yeast fermentation liquid (obtained in Production Example 6) 5.00 4. Paraoxybenzoate 0.10 5. citric acid 0.10 7. Sodium citrate 0.30 7.1, 3-butylene glycol 4.00 Disodium edetate 0.019. Purified water Proper quantity production method A. 1 to 10 are uniformly stirred and dissolved. B. A is filled in a container, and is used as a product after inspection. Rub face and appropriate dosage and dosage. <Formulation Example 4> Cream pack (% by weight) Polyethylene glycol monostearate (40 E.0.) 2.00 2. 2. Self-emulsifying glyceryl monostearate 5.00 Stearic acid 5.00 4. Behenyl alcohol 0.50 5. Squalane 15.00 6. 6. Cetyl octanoate 5.00 7. Yeast fermented liquid (obtained in Production Example 2) 5.00 Paraoxybenzoate 0.20 9.1 1,3-butylene glycol 5.00 10. Disodium edetate 0.01 11. Purified water Proper quantity production method A. Heat and dissolve 1 to 7. B. Heat and dissolve 8-12. C. A. Add B to A, emulsify, stir and cool. After cooling, C is filled into a container, and is used as a product after inspection. Rub face and appropriate dosage and dosage. <Formulation Example 5> Ointment (% by weight) 1. Polyoxyethylene sorbitan monostearate (20E.0.) 1.00 2. Polyoxyethylene sorbite tetraoleate (60E.0.) 1.50 Self-emulsifying glyceryl monostearate 1.50 4. Salami beeswax 2.00 5. Paraffin 2.00 6. Stearic acid 3.00 7. 7. Behenyl alcohol 3.00 Liquid paraffin 5.00 9. Avocado oil 12.00 10. Vitamin E 12.00 11. 11. Yeast fermentation liquor (obtained in Production Example 4) 10.00 Paraoxybenzoic acid ester 0.20 13.1,3 Butylene glycol 5.00 14. Purified water qs Production method A. Heat and dissolve 1-11. B. Heat and dissolve 12-15. C. A. Add B to A, emulsify, stir and cool. After cooling, C is filled into a container, and is used as a product after inspection. Rub face and appropriate dosage and dosage. <Formulation Example 6> Emulsion (% by weight) 1. Polyoxyethylene sorbitan monostearate (20E.0.) 1.00 2. Polyoxyethylene sorbite tetraoleate (60E.0.) 0.50 3. Lipophilic glyceryl monostearate 1.00 Stearic acid 0.50 5. Behenyl alcohol 0.50 6. Avocado oil 4.00 7. 7. Glyceryl trioctanoate 4.00 8. Yeast fermentation liquor (obtained in Production Example 5) 3.00 Paraoxybenzoate 0.20 10.1,3 Butylene glycol 5.00 11. Xanthan gum 0.14 12. Disodium edetate 0.01 13. Purified water Proper quantity production method A. Heat and dissolve 1-8. B. Heat and dissolve 9-14. C. A. Add B to A, emulsify, stir and cool. After cooling, C is filled into a container, and is used as a product after inspection. Rub face and appropriate dosage and dosage. According to the present invention, a saccharifying enzyme specific to wheat is provided.
Inoculate a specific bacterial species into the saccharified solution obtained by adding
An external preparation that is remarkably excellent in a melanin production inhibitory effect comprising a yeast culture solution or a yeast extract provided is provided. It is preferably used.
【図面の簡単な説明】
【図1】本発明の糖液の酵母培養液の電動度を、ヒアル
ロン酸ナトリウムの電動度と対比して示すグラフであ
る。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a graph showing the electric power of a yeast culture solution of the sugar solution of the present invention in comparison with the electric power of sodium hyaluronate.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI A61K 38/00 A61P 17/00 A61P 17/00 A61K 37/02 (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 C12N 1/16 - 1/19 JICSTファイル(JOIS)──────────────────────────────────────────────────の Continuation of front page (51) Int.Cl. 7 identification code FI A61K 38/00 A61P 17/00 A61P 17/00 A61K 37/02 (58) Field surveyed (Int.Cl. 7 , DB name) A61K 7/00-7/50 C12N 1/16-1/19 JICST file (JOIS)
Claims (1)
ゼとグルコアミラーゼを同時添加して得られた糖化液
に、菌種としてサッカロミセスセレビシエまたはサッカ
ロミセスカールスベルゲンシスを接種した酵母培養液ま
たは培養エキスを含有することを特徴とするメラニン生
成抑制外用剤。(57) [Claims 1] α-Amirror as a saccharifying enzyme in barley
An external preparation for suppressing melanin production, comprising a yeast culture solution or a culture extract inoculated with Saccharomyces cerevisiae or Saccharomyces curlsbergensis as a bacterial species to a saccharified solution obtained by simultaneously adding zeolites and glucoamylase .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP00634393A JP3435181B2 (en) | 1993-01-19 | 1993-01-19 | External preparation for melanin production suppression |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP00634393A JP3435181B2 (en) | 1993-01-19 | 1993-01-19 | External preparation for melanin production suppression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH06211639A JPH06211639A (en) | 1994-08-02 |
| JP3435181B2 true JP3435181B2 (en) | 2003-08-11 |
Family
ID=11635728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP00634393A Expired - Lifetime JP3435181B2 (en) | 1993-01-19 | 1993-01-19 | External preparation for melanin production suppression |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3435181B2 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001131081A (en) * | 1999-11-09 | 2001-05-15 | Shinei Ferumentekku:Kk | Eraser of superoxide and drink |
| JP2001131052A (en) * | 1999-11-09 | 2001-05-15 | Shinei Ferumentekku:Kk | Cosmetics |
| KR100383137B1 (en) * | 2000-11-21 | 2003-05-12 | 엔프라니 주식회사 | Moisturing cosmetic composition containing a blend comprising extracts from rye and Ulmus Macrocarpa Hance |
| JPWO2003057228A1 (en) * | 2001-12-28 | 2005-05-12 | ネオケミア株式会社 | Carbon dioxide external composition and method for producing the same |
| JP2003335659A (en) * | 2002-05-20 | 2003-11-25 | Matsukawa Kagaku:Kk | Cosmetic |
| JP3704342B2 (en) * | 2003-06-17 | 2005-10-12 | 株式会社オードビー・ジャポン | Moisturizer and skin cosmetics and beauty foods and drinks containing the moisturizer |
| JP5147805B2 (en) * | 2004-03-15 | 2013-02-20 | 共栄化学工業株式会社 | Cosmetics |
| JP4563225B2 (en) * | 2004-03-15 | 2010-10-13 | 共栄化学工業株式会社 | Cosmetics |
| JP2010138139A (en) * | 2008-12-15 | 2010-06-24 | Kyoei Kagaku Kogyo Kk | Skin-lightening agent and skin-lightening cosmetic |
| JP5663187B2 (en) * | 2010-03-31 | 2015-02-04 | 株式会社ナリス化粧品 | Antioxidants, UV damage inhibitors and anti-aging cosmetics |
| CN117298012B (en) * | 2023-10-17 | 2024-05-17 | 清远市望莎生物科技有限公司 | Yeast fermentation composition for reducing cytotoxicity, application thereof and daily chemicals |
-
1993
- 1993-01-19 JP JP00634393A patent/JP3435181B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| フレグランス ジャーナル,1992年,第20巻,第3号,pp.18−21 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06211639A (en) | 1994-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3818674B2 (en) | Topical skin preparation | |
| CN115554226B (en) | Multi-strain fermentation filtrate and preparation method and application thereof | |
| KR20100135871A (en) | Active ingredient that stimulates proliferation and / or activity of fibroblasts | |
| KR101663946B1 (en) | Cosmetic composition containing an ginsenoside Rg3 reinforced extract of fermentative Ginseng flower(Panax ginseng C. A. Meyer) by Aureobasidium pullulans | |
| JP3435181B2 (en) | External preparation for melanin production suppression | |
| JP2017214349A (en) | Cosmetics and oral compositions | |
| JP5698586B2 (en) | Cosmetics | |
| KR101855207B1 (en) | Cosmetic composition containing fermentative extract of terminalia ferdinandiana with increased amount of vitamin c fermented by aureobasidium pullulans | |
| KR20100006796A (en) | Anti-aging cosmetic composition comprising herb ferment extract | |
| KR100727743B1 (en) | Skin moisturizing composition containing camphorol as an active ingredient, skin barrier function enhancement, and skin external cosmetic composition for inducing differentiation of keratinocytes | |
| JP6637226B2 (en) | External preparation for skin | |
| JP2008133270A (en) | Agent for promoting production of collagen and hyaluronic acid | |
| JP2021004214A (en) | Combinational fermented product | |
| CN115518012A (en) | Composition with effects of inhibiting melanin protein and improving black eye and pouch and application | |
| JP6510744B2 (en) | Cosmetics | |
| JP3278138B2 (en) | External preparation for skin | |
| JP2015134737A (en) | External preparation for skin | |
| JPH03112912A (en) | Cosmetic composition | |
| JP3823373B2 (en) | Arginase activity promoter | |
| KR101843976B1 (en) | Cosmetic composition comprising extract of geminated phaseolus radiatus fermented by aureobasidium pullulans | |
| CN117017845A (en) | Application of Sparassis crispa concentrated solution, anti-aging whitening composition and cosmetic | |
| JP3083105B2 (en) | Cosmetics | |
| KR20150058635A (en) | Composition containing fermentated opuntia humifusa showing biological activity of skin | |
| JP2019182771A (en) | Poria sclerotium fermentation extract and method for producing the same | |
| KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20030520 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090530 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100530 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110530 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120530 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130530 Year of fee payment: 10 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130530 Year of fee payment: 10 |